한국어
English
日本語
中文(简体)
Badanemjeong 300 Milligrams (Bada Dose Start)
300mg
Tablet · Prescription medication
Tanabe Pharma Korea Co., Ltd.
Badadustart is a drug that promotes hematopoiesis for the treatment of anemia.
MFDS ingredient code M283461
Badadustart is a drug used for the treatment of anemia, developed to improve the condition of oxygen deficiency in the body. This ingredient is particularly utilized in the management of anemia in patients with chronic kidney disease. It increases the production of red blood cells in the blood, enhancing oxygen-carrying capacity.
Badadustart activates proteins that detect hypoxia in the body, increasing the secretion of erythropoietin, a hormone necessary for red blood cell production. This promotes red blood cell production in the bone marrow, alleviating symptoms of anemia. It also improves iron utilization, assisting the hematopoietic process.
Approved uses differ by product. Check each product's information for its actual use.
Unlike traditional erythropoietin injections, Badadustart can be taken orally, making it convenient. Additionally, it acts as a hypoxia-inducible factor (HIF) regulator, with a unique mechanism of action that distinguishes it from other hematopoietic agents. As a result, it has gained attention as a new alternative for treating anemia in patients with chronic kidney disease.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
